Scientists test safety of combining new gout medications
NCT ID NCT06665425
Summary
This early-stage study aims to understand how two gout medications, epaminurad and C2406, interact when taken together. It will involve 18 healthy adults to measure the levels of each drug in the body and check for safety. The goal is to gather basic information to guide future research, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital Clinical Trials Center
Seoul, Seoul, 110-744, South Korea
Conditions
Explore the condition pages connected to this study.